Azelaic acid, a naturally occurring dicarboxylic acid derived from grains such as wheat, barley, and rye, has garnered significant attention in dermatology and cosmetic science for its multifaceted bioactivity. This article explores the molecular and cellular mechanisms, the clinical evidence supporting its efficacy, its regulatory status, and formulation considerations relevant to its use in cosmetics and therapeutic skincare products.
Cosmetic Ingredients Series
Below is a list of the most recent articles about cosmetic ingredients, to view the full list, click here.
What is Azelaic Acid?
Azelaic acid (nonanedioic acid) is a saturated, nine-carbon dicarboxylic acid found naturally in whole grains and produced endogenously by Malassezia furfur, a species of yeast that is part of the normal human skin microbiota. It was originally identified as a byproduct of yeast metabolism and has since been extensively studied for its antimicrobial, keratolytic, and anti-inflammatory properties.
In dermatology, it is commonly used in topical formulations ranging from 10% to 20% concentrations, either as a prescription treatment or over-the-counter cosmetic. It is considered particularly effective in treating rosacea, acne vulgaris, and hyperpigmentation disorders, such as melasma and post-inflammatory hyperpigmentation (PIH).
Mechanism of Action of Azelaic Acid
Azelaic acid (C9H16O4) exerts multiple effects at the cellular and molecular level, making it a versatile ingredient in cosmetic and therapeutic skincare.
Inhibition of Mitochondrial Enzymes and Tyrosinase
Azelaic acid (AA) selectively inhibits mitochondrial oxidoreductases, including NADPH-dependent enzymes involved in cellular respiration and oxidative stress. This contributes to its antiproliferative effect on abnormal melanocytes, making it beneficial for conditions like melasma.
Additionally, AA inhibits tyrosinase, the key rate-limiting enzyme in melanin synthesis. By chelating copper at the active site of tyrosinase, AA reduces melanin production, offering depigmenting effects without cytotoxicity to normal melanocytes.
Antimicrobial Activity
Azelaic acid exhibits bacteriostatic activity against Propionibacterium acnes and Staphylococcus epidermidis by interfering with microbial DNA synthesis. It inhibits the synthesis of microbial proteins and reactive oxygen species (ROS), reducing inflammation and bacterial load in acne lesions.
Keratolytic and Comedolytic Effects
Azelaic acid normalizes keratinocyte differentiation and reduces hyperkeratinization—key pathogenic steps in comedone formation. This is thought to be mediated by modulation of peroxisome proliferator-activated receptors (PPARs) and downstream gene expression involved in cell cycle regulation and differentiation.
Anti-inflammatory Properties
Azelaic acid reduces pro-inflammatory cytokines such as IL-1β, TNF-α, and IL-6 by inhibiting nuclear factor-kappa B (NF-κB) signaling pathways. It also scavenges free radicals, further limiting inflammation and oxidative damage in the skin.
Short and Long-term Benefits
Short-term: Reduction in inflammation, decreased bacterial load, and improved lesion count in acne and rosacea.
Long-term: Lightening of hyperpigmentation, reduction in melasma severity, and sustained skin barrier improvement with low irritation potential.
Clinical Evidence
Numerous randomized controlled trials (RCTs) support the efficacy of AA in treating dermatological conditions:
- Acne Vulgaris: A double-blind study comparing 20% AA cream with 0.05% tretinoin and 5% benzoyl peroxide demonstrated comparable efficacy with significantly less irritation.
- Rosacea: AA 15% gel reduced inflammatory lesions by up to 70% in clinical trials over 15 weeks.
- Hyperpigmentation: A study showed that 20% AA cream significantly improved melasma after 24 weeks, performing similarly to 4% hydroquinone with fewer adverse effects.
Regulatory Status
Azelaic acid is regulated differently based on concentration and intended use:
- In the European Union, AA is approved for both cosmetic and medicinal use. Products containing ≤10% are typically regulated as cosmetics, while higher concentrations (15–20%) are considered medicinal and require approval.
- In the United States, AA 15% gel and 20% cream are FDA-approved drugs for rosacea and acne, respectively, under brand names like Finacea® and Azelex®.
Safety and Historical Use
Azelaic acid has a long-standing safety profile, supported by decades of topical use. It is non-mutagenic, non-teratogenic, and exhibits low systemic absorption (<4% of applied dose). It belongs to a broader family of alpha- and beta-hydroxy acids, which have a strong history of safe cosmetic use. These include glycolic acid, lactic acid, and salicylic acid—many of which, like AA, function by promoting exfoliation and epidermal renewal.
Comprehensive toxicological assessments by the Scientific Committee on Consumer Safety (SCCS) and Cosmetic Ingredient Review (CIR) panel have affirmed the safety of AA in leave-on products at concentrations up to 10%.
Formulation Considerations
Solubility: Azelaic acid has poor solubility in water and most oils, requiring the use of microemulsions, liposomes, or polymeric gels to ensure proper skin delivery and stability (Bonina et al., 1999).
pH Sensitivity: AA remains stable across a broad pH range (4–6), making it compatible with other active ingredients, although low-pH environments can increase irritation potential.
Compatibility: Often combined with niacinamide, salicylic acid, or hyaluronic acid to boost efficacy and tolerability. Avoid formulation with strong acids (e.g., AHAs at very low pH) to prevent irritation.
